Human herpesvirus 8 seroprevalence among Tobago women and the role of sexual lifestyle behavior

Journal of Medical Virology

Volumn 81, Issue 2, 2009, Pages 264-270

  McDonald, Alicia C ^a,b   Ragin, Camille C ^a,b   Jenkins, Frank J ^c   Weissfeld, Joel ^a,b   Wilson, John ^a   Wheeler, Victor W ^d   Wilson, Jaquie B ^d   Bunker, Clareann H ^a,b   Taioli, Emanuela ^a,b  

^a UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^b UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

^c UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^d Tobago Health Studies Office   (Trinidad and Tobago)

Author keywords

Caribbean; Human herpesvirus 8; Sexual transmission

Indexed keywords

ADULT; AGED; ARTICLE; CANCER SCREENING; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; FEMALE; HERPES SIMPLEX; HUMAN; HUMAN HERPESVIRUS 8; IMMUNOFLUORESCENCE TEST; LIFESTYLE; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; SEROPREVALENCE; SEXUAL BEHAVIOR; SEXUAL INTERCOURSE; SEXUAL TRANSMISSION; STATISTICAL SIGNIFICANCE; VIRUS TRANSMISSION; ADOLESCENT; BLOOD; CELL LINE; DISEASE TRANSMISSION; EPIDEMIOLOGY; GENETICS; HERPES VIRUS INFECTION; IMMUNOLOGY; ISOLATION AND PURIFICATION; MIDDLE AGED; RISK FACTOR; SEXUALLY TRANSMITTED DISEASE; TRINIDAD AND TOBAGO; VIROLOGY;

ADOLESCENT; ADULT; AGED; ANTIBODIES, VIRAL; CELL LINE; CROSS-SECTIONAL STUDIES; FEMALE; HERPESVIRIDAE INFECTIONS; HERPESVIRUS 8, HUMAN; HUMANS; LIFE STYLE; MALE; MIDDLE AGED; RISK FACTORS; SEROEPIDEMIOLOGIC STUDIES; SEXUAL BEHAVIOR; SEXUALLY TRANSMITTED DISEASES, VIRAL; TRINIDAD AND TOBAGO; YOUNG ADULT;

HUMAN HERPESVIRUS 8;

VIRUS ANTIBODY;

EID: 61749088138     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.21346     Document Type: Article

References (43)

1. Ablashi D, Chatlynne L, Cooper H, Thomas D, Yadav M, Norhanom AW, Chandana AK, Churdboonchart V, Kulpradist SA, Patnaik M, Liegmann K, Masood R, Reitz M, Cleghorn F, Manns A, Levine PH, Rabkin C, Biggar R, Jensen F, Gill P, Jack N, Edwards J, Whitman J, Boshoff C. 1999. Seroprevalence of human herpesvirus-8 (HHV-8) in countries of Southeast Asia compared to the USA, the Caribbean and Africa. Br J Cancer 81:893-897.
2. Bunker CH, Patrick AL, Konety BR, Dhir R, Brufsky AM, Vivas CA, Becich MJ, Trump DL, Kuller LH. 2002. High prevalence of screening-detected prostate cancer among Afro-Caribbeans: The Tobago Prostate Cancer Survey. Cancer Epidemiol Biomarkers Prev 11:726-729.
3. Cannon MJ, Dollard SC, Smith DK, Klein RS, Schuman P, Rich JD, Vlahov D, Pellett PE, Group HIVERS. 2001. Blood-borne and sexual transmission of human herpesvirus 8 in women with or at risk for human immunodeficiency virus infection. N Engl J Med 344:637-643.
4. Cannon MJ, Dollard SC, Black JB, Edlin BR, Hannah C, Hogan SE, Patel MM, Jaffe HW, Offermann MK, Spira TJ, Pellett PE, Gunthel CJ. 2003. Risk factors for Kaposi's sarcoma in men seropositive for both human herpesvirus 8 and human immunodeficiency virus. AIDS 17:215-222.
5. Cattani P, Cerimele F, Porta D, Graffeo R, Ranno S, Marchetti S, Ricci R, Capodicasa N, Fuga L, Amico R, Cherchi G, Gazzilli M, Zanetti S, Fadda G. 2003. Age-specific seroprevalence of human herpesvirus 8 in Mediterranean regions. Clin Microbiol Infect 9:274-279.
6. Cesarman E, Chang Y, Moore PS, Said JW, Knowles DM. 1995. Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas. [See comment]. N Engl J Med 332:1186-1191.
7. Chang Y, Cesarman E, Pessin MS, Lee F, Culpepper J, Knowles DM, Moore PS. 1994. Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. [See comment]. Science 266:1865-1869.
8. Cunha AMG, Caterino-de-Araujo A, Costa SCB, Santos-Fortuna E, Boa-Sorte NCA, Goncalves MS, Costa FF, Galvao-Castro B. 2005. Increasing seroprevalence of human herpesvirus 8 (HHV-8) with age confirms HHV-8 endemicity in Amazon Amerindians from Brazil. J Gen Virol 86:2433-2437.
9. Davidovici B, Karakis I, Bourboulia D, Ariad S, Zong J, Benharroch D, Dupin N, Weiss R, Hayward G, Sarov B, Boshoff C. 2001. Seroepidemiology and molecular epidemiology of Kaposi's sarcoma-associated herpesvirus among Jewish population groups in Israel. J Natl Cancer Inst 93:194-202.
10. de Sanjose S, Marshall V, Sola J, Palacio V, Almirall R, Goedert JJ, Bosch FX, Whitby D. 2002. Prevalence of Kaposi's sarcoma-associated herpesvirus infection in sex workers and women from the general population in Spain. Int J Cancer 98:155-158.
11. Dr. Elizabeth Quamina Cancer Registry of Trinidad & Tobago. 2008. Mount Hope, Trinidad W.I.: North Central Regional Health Authority.
12. Dupin N, Fisher C, Kellam P, Ariad S, Tulliez M, Franck N, van Marck E, Salmon D, Gorin I, Escande JP, Weiss RA, Alitalo K, Boshoff C. 1999. Distribution of human herpesvirus-8 latently infected cells in Kaposi's sarcoma, multicentric Castleman's disease, and primary effusion lymphoma. Proc Natl Acad Sci USA 96:4546-4551.
13. Engels EA, Eastman H, Ablashi DV, Wilks RJ, Braham J, Manns A. 1999. Risk of transfusion-associated transmission of human herpesvirus 8. J Natl Cancer Inst 91:1773-1775.
14. Engels EA, Sinclair MD, Biggar RJ, Whitby D, Ebbesen P, Goedert JJ, Gastwirth JL. 2000. Latent class analysis of human herpesvirus 8 assay performance and infection prevalence in sub-Saharan Africa and Malta. Int J Cancer 88:1003-1008.
15. Engels EA, Atkinson JO, Graubard BI, McQuillan GM, Gamache C, Mbisa G, Cohn S, Whitby D, Goedert JJ. 2007. Risk factors for human herpesvirus 8 infection among adults in the United States and evidence for sexual transmission. [See comment]. J Infect Dis 196:199-207.
16. Ferlay J, Bray F, Pisani P, Parkin D. 2004. Globocan 2002: Cancer Incidence, Mortality, and Prevalence Worldwide IARC CancerBase. No. 5 version 2.0. Lyon: IARC Press.
17. Fernandez L, Serraino D, Rezza G, Lence J, Ortiz RM, Cruz T, Vaccarella S, Sarmati L, Andreoni M, Franceschi S. 2002. Infection with human herpesvirus type 8 and human T-cell leukaemia virus type 1 among individuals participating in a case-control study in Havana City, Cuba. Br J Cancer 87:1253-1256.
18. Gandhi M, Koelle DM, Ameli N, Bacchetti P, Greenspan JS, Navazesh M, Anastos K, Greenblatt RM. 2004. Prevalence of human herpesvirus-8 salivary shedding in HIV increases with CD4 count. J Dent Res 83:639-643.
19. Goedert JJ, Charurat M, Blattner WA, Hershow RC, Pitt J, Diaz C, Mofenson LM, Green K, Minkoff H, Paul ME, Thomas DL, Whitby D, Women and Infants Transmission S. 2003. Risk factors for Kaposi's sarcoma-associated herpesvirus infection among HIV-1-infected pregnant women in the USA. AIDS 17:425-433.
20. Hoffman LJ, Bunker CH, Pellett PE, Trump DL, Patrick AL, Dollard SC, Keenan HA, Jenkins FJ. 2004. Elevated seroprevalence of human herpesvirus 8 amongmen with prostate cancer. J Infect Dis 189:15-20.
21. Hudnall SD, Chen T, Rady P, Tyring S, Allison P. 2003. Human herpesvirus 8 seroprevalence and viral load in healthy adult blood donors. Transfusion 43:85-90.
22. Jenkins FJ, Hoffman LJ, Liegey-Dougall A. 2002. Reactivation of and primary infection with human herpesvirus 8 among solid-organ transplant recipients. J Infect Dis 185:1238-1243.
23. Landis J, Koch G. 1977. The measurement of observer agreement for categorical data. Biometrics 33:159-174.
24. Lennette ET, Blackbourn DJ, Levy JA. 1996. Antibodies to human herpesvirus type 8 in the general population and in Kaposi's sarcoma patients. [See comment]. Lancet 348:858-861.
25. Manns A, Strickler HD, Hanchard B, Manassaram DM, Waters D, Ablashi DV. 1998. Age- and sex-specific seroprevalence of human herpesvirus 8 in Jamaica. [Comment]. J Natl Cancer Inst 90:1102-1104.
26. Martro E, Esteve A, Schulz TF, Sheldon J, Gambus G, Munoz R, Whitby D, Casabona J, Euro-Shaks Study Group. 2007. Risk factors for human Herpesvirus 8 infection and AIDS-associated Kaposi's sarcoma among men who have sex with men in a European Multicentre Study. Int J Cancer 120:1129-1135.
27. Masini C, Abeni DD, Cattaruzza MS, Capuano M, Pedicelli C, Cerimele F, Pasquini P, Cerimele D, Fadda G, Cattani P. 2000. Antibodies against human herpesvirus 8 in subjects with non-venereal dermatological conditions. Br J Dermatol 143:484-490.
28. Moore PS, Chang Y. 2001. Kaposi's sarcoma-associated herpesvirus. In: Knipe D, Howley P, editors. Field's virology, 4th edition. Philadelphia, PA: Lippincott Williams & Wilkins. pp 2803-2833.
29. Pauk J, Huang ML, Brodie SJ, Wald A, Koelle DM, Schacker T, Celum C, Selke S, Corey L. 2000. Mucosal shedding of human herpesvirus 8 in men. [See comment]. N Engl J Med 343:1369-1377.
30. Pellett PE, Wright DJ, Engels EA, Ablashi DV, Dollard SC, Forghani B, Glynn SA, Goedert JJ, Jenkins FJ, Lee TH, Neipel F, Todd DS, Whitby D, Nemo GJ, Busch MP, Retrovirus Epidemiology Donor S. 2003. Multicenter comparison of serologic assays and estimation of human herpesvirus 8 seroprevalence among US blood donors. Transfusion 43:1260-1268.
31. Pica F, Volpi A. 2007. Transmission of human herpesvirus 8: An update. Curr Opin Infect Dis 20:152-156.
32. Plancoulaine S, Abel L, Tregouet D, Duprez R, van Beveren M, Tortevoye P, Froment A, Gessain A. 2004. Respective roles of serological status and blood specific antihuman herpesvirus 8 antibody levels in human herpesvirus 8 intrafamilial transmission in a highly endemic area. Cancer Res 64:8782-8787.
33. Quinlivan EB, Wang RX, Stewart PW, Kolmoltri C, Regamey N, Erb P, Vernazza PL, Swiss HIVCS. 2001. Longitudinal sero-reactivity to human herpesvirus 8 (KSHV) in the Swiss HIV Cohort 4.7 years before KS. J Med Virol 64:157-166.
34. Ragin CCR, Wheeler VW, Wilson JB, Bunker CH, Gollin SM, Patrick AL, Taioli E. 2007. Distinct distribution of HPV types among cancer-free Afro-Caribbean women from Tobago. Biomarkers 12:510-522.
35. Rezza G, Tchangmena OB, Andreoni M, Bugarini R, Toma L, Bakary DK, Glikoutou M, Sarmati L, Monini P, Pezzotti P, Ensoli B. 2000. Prevalence and risk factors for human herpesvirus 8 infection in northern Cameroon. Sex Transm Dis 27:159-164.
36. Schulz TF, Sheldon J, Greensill J. 2002. Kaposi's sarcoma associated herpesvirus (KSHV) or human herpesvirus 8 (HHV8). Virus Res 82:115-126.
37. Serraino D, Cerimele D, Piselli P, Aztori L, Farchi F, Carletti F, Navarra A, Masala MV, Rezza G. 2006. Infection with human herpesvirus type 8 and Kaposi's sarcoma in Sardinia. Infection 34:39-42.
38. Smith NA, Sabin CA, Gopal R, Bourboulia D, Labbet W, Boshoff C, Barlow D, Band B, Peters BS, de Ruiter A, Brown DW, Weiss RA, Best JM, Whitby D. 1999. Serologic evidence of human herpesvirus 8 transmission by homosexual but not heterosexual sex. J Infect Dis 180:600-606.
39. Soulier J, Grollet L, Oksenhendler E, Cacoub P, Cazals-Hatem D, Babinet P, d'Agay MF, Clauvel JP, Raphael M, Degos L, Sigaux F. 1995. Kaposi's sarcoma-associated herpesvirus-like DNA sequences in multicentric Castleman's disease. [See comment]. Blood 86:1276-1280.
40. Tanzi E, Zappa A, Caramaschi F, Amendola A, Lasagna D, Gatti L, Ascoli V, Rezza G, Zanetti AR. 2005. Human herpesvirus type 8 infection in an area of Northern Italy with high incidence of classical Kaposi's sarcoma. J Med Virol 76:571-575.
41. Taylor MM, Chohan B, Lavreys L, Hassan W, Huang M-L, Corey L, Ashley Morrow R, Richardson BA, Mandaliya K, Ndinya-Achola J, Bwayo J, Kreiss J. 2004. Shedding of human herpesvirus 8 in oral and genital secretions from HIV-1-seropositive and -seronegative Kenyan women. J Infect Dis 190:484-488.
42. Vitale F, Briffa DV, Whitby D, Maida I, Grochowska A, Levin A, Romano N, Goedert JJ. 2001. Kaposi's sarcoma herpes virus and Kaposi's sarcoma in the elderly populations of 3 Mediterranean islands. Int J Cancer 91:588-591.
43. Zavitsanou A, Sypsa V, Petrodaskalaki M, Psichogiou M, Katsoulidou A, Boletis J, Hadjiconstantinou V, Karalis D, Kalapothaki V, Hatzakis A. 2006. Human herpesvirus 8 infection in hemodialysis patients. Am J Kidney Dis 47:167-170.